|
It was reported by customer that multiple product quality concerns that have been identified with bd sterile syringes from several lots.Verbatim: complaint via email.Email attached.I am writing to report multiple product quality concerns that have been identified with bd sterile syringes from several lots currently in our inventory.These issues have been observed across multiple syringes and lot numbers, raising concerns regarding product quality and manufacturing consistency.The defects identified include: extra measurement markings printed on syringe barrels black specks present on syringe barrels unidentifiable debris observed within syringe barrels missing graduation markings on the barrel the affected products and lot numbers are as follows: 50 ml sterile syringes lot 6138808: two syringes identified with defects lot 6098162: two syringes identified with defects lot 6098177: two syringes identified with defects lot 6131767: 26 defective syringes identified 5 ml sterile syringe lot 6114407: one syringe identified with missing graduation markings on the side of the barrel these defects were identified during routine inspection.Due to concerns regarding product quality and the potential impact on accurate medication preparation and administration, the affected syringes were immediately removed from use and were not utilized for patient care.The syringes have been retained and are available for return to bd to support your investigation.We would appreciate your assessment of these findings and any guidance regarding product return procedures, replacement product, and investigation activities.Please advise on the next steps for submitting the affected samples, photographs, or any additional information needed to support your review.".
|